Phychem Technologies Limited, a Nashik-based manufacturer of rotational moulding compounds, has filed its Draft Red Herring Prospectus (DRHP) with SEBI. The company plans an SME IPO with identified proceeds of ₹10.65 crore. The issue is entirely fresh, with no Offer for Sale (OFS), aimed at debt repayment and capacity expansion.

Company Overview

Phychem Technologies Limited is engaged in the manufacturing of rotational moulding compounds, which serve as key raw materials for hollow plastic products. Incorporated in 2013, the company operates from a single facility in Nashik, Maharashtra. Its product portfolio includes customized Polyethylene-based compounds, Color Powders, PE Foam compounds, and specialty additives. The company serves a diversified customer base across 21 countries and 24 Indian states, catering to sectors such as building & construction, water management, agriculture, automotive, and consumer products. The management team is led by Managing Director Umakant Nivrutti Savadekar, who brings 21 years of industry experience.

Offer Details

The company has structured the issue as a Fresh Issue under the SME platform. The price band and lot size are not yet available in the DRHP data provided. The issue is scheduled to open on 31-Aug-2026 and close on 02-Sep-2026.

Objects of the Issue

The proceeds from the issue will be utilized for the following purposes:

• Repayment of outstanding borrowings (SIDBI & Kotak Mahindra Bank): ₹2.50 Crore
• Capital expenditure – Procurement of plant & machinery: ₹5.15 Crore
• Working capital requirements: ₹3.00 Crore
• General Corporate Purpose: Not Specified amount

Financial Highlights

The company has shown consistent growth in revenue and profitability over the last three years. Revenue from operations grew from ₹46.97 Cr in FY2024 to ₹56.47 Cr in FY2026. Profit After Tax (PAT) improved significantly from ₹1.69 Cr in FY2024 to ₹4.09 Cr in FY2026. Margins have expanded, with PAT margin rising from 3.55% to 7.12% over the same period.

Risk Factors

Investors should note the following material risks disclosed in the DRHP:

• Single Manufacturing Facility: The company operates from one location in Nashik, making it vulnerable to operational disruptions, natural disasters, or regulatory issues.
• Customer Concentration: Top 10 customers contribute approximately 50–53% of revenue, with the single largest customer accounting for 13–16%. There are no long-term agreements with customers.
• Supplier Concentration: The single largest supplier contributes over 60% of purchases, exposing the company to supply disruptions and price volatility without long-term contracts.
• Export Exposure: Exports account for 23–31% of revenue, subjecting the company to foreign exchange fluctuations and international trade risks without hedging.
• Working Capital Strain: Operating cash flow declined sharply in FY2026 to ₹0.78 Cr from ₹2.53 Cr in FY2025, indicating increased working capital absorption.

Valuation & Peer Comparison

Peer comparison data is not available in the provided DRHP. The pre-issue total equity stands at ₹13.79 Crore as of FY2026. Valuation metrics such as P/E ratio cannot be determined until the price band is announced. Investors should evaluate the offer against the FY2026 PAT of ₹4.09 Crore once pricing details are disclosed.

Bottom Line

Phychem Technologies presents a profile of improving profitability and margin expansion, supported by a diversified customer base and export presence. However, the reliance on a single manufacturing facility, high concentration in both customers and suppliers, and a sharp decline in operating cash flow in FY2026 are significant concerns. The use of proceeds for debt repayment and capacity expansion aligns with growth objectives, but investors must weigh these against the inherent risks of the SME segment and the plastics industry.